Menu
← Oncology Approval Tracker
FDA DECISION ·
Tecartus
brexucabtagene autoleucel · Kite Pharma
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with relapsed or refractory mantle cell lymphoma.
LAMPGEN ANALYSIS
Why it matters
Introduced CD19-directed CAR T-cell therapy for mantle cell lymphoma under accelerated approval.
What research teams should watch
Plan leukapheresis, manufacturing and bridging care and confirm readiness for early toxicity monitoring.
PRIMARY RECORDS